Improving the Diagnosis of Liver Disease in Primary Care Patients with Abnormal Liver Function
Improving the Diagnosis of Liver Disease in Primary Care Patients with Abnormal Liver Function
批准号:
10163178
负责人:
Andrew David Schreiner
金额:
$17.25万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-17 至 2023-02-28
关键词:
Acute Liver FailureAddressAgeAlcohol consumptionAlcoholic Liver DiseasesAlcoholsAmericasAntiviral TherapyBiometryCardiovascular DiseasesCaringCause of DeathChronicCirrhosisClinicClinicalClinical ManagementCommunitiesDataDeath RateDiagnosisDiagnosticDiagnostic ErrorsDiseaseEarly DiagnosisEconomic PolicyElectronic Health RecordEuropeFundingGoalsHealth PolicyHealth Services ResearchHealthcareHeart DiseasesHepatitis C TherapyHepatologyHerbal supplementHyperglycemiaHypertensionIndividualInfectionInformation TechnologyInstitute of Medicine (U.S.)InterventionLaboratoriesLaboratory StudyLeadLinkLiverLiver FailureLiver Function TestsLiver diseasesMalignant NeoplasmsMalignant neoplasm of liverMedicineMentorshipModelingObesityOutcomePatient CarePatient-Focused OutcomesPatientsPatternPharmaceutical PreparationsPharmacologyPlayPortal HypertensionPositioning AttributePredictive AnalyticsPrimary Care PhysicianPrimary Health CareProcessRecording of previous eventsResearchResourcesRiskRisk EstimateRoleTestingTimeTrainingUnited StatesViral hepatitisWorkaccurate diagnosisbasecareerclinical riskclinically significanteffectiveness evaluationexperiencehealth care deliveryhealth economicsimprovedintravenous drug useliver functionliver injurymortalitynon-alcoholic fatty liver diseasenovel strategiespredictive modelingprimary care settingpsychosocialsupport tools
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Improving the Diagnosis of Liver Disease in Primary Care Patients with Abnormal Liver Function Tests
Through Predictive Modeling
Reducing diagnostic error has been identified by the Institute of Medicine as a top national priority. Diagnostic
errors pervade all of healthcare, with the average individual experiencing one major error during their lifetime.
Therefore, improving the diagnostic process and reducing diagnostic error is not only highly appropriate for all
patients, but will play a crucial role in optimizing the quality and value of healthcare delivery in the United
States.1
Liver disease, with complications including acute liver failure, cirrhosis, and liver cancer ranks as a leading
cause of death in America and over recent years has had a significant climb in age-adjusted mortality, while
death rates from heart disease and cancer have fallen.2 Despite the increasing preventability of liver-related
conditions through early recognition and treatment, the toll of chronic and end stage liver disease continues to
rise.3
The traditional diagnostic process, a synthesis of information gathered from history, physical exam, and
laboratory testing, performs poorly in the detection of early liver disease.4,5 Instead, clinicians rely more heavily
on laboratory studies, and liver function tests (LFTs) in particular.6 Abnormal LFTs are among the most
frequently encountered findings in medicine.7,8 Currently, primary care clinicians currently lack the ability to
consistently identify liver-related disease from these abnormalities.9-12
Preliminary data in primary care emphasize the immense scope of the problem; in studies from Europe, LFTs
have been found elsewhere to be abnormal in nearly 1 in 5 people.13,14 In our preliminary studies, we have up
to 40% of patients seen in an academic primary care clinic possessed at least one abnormal LFT. Further,
these abnormal liver tests are inappropriately or inadequately followed-up. These data and our own
experience indicate that primary care physicians (PCPs) lack the resources to reliably identify and accurately
diagnose liver-related diseases amongst these many abnormal LFTs.
In this proposal, the candidate and his mentorship team seek to harness inter-professional teamwork and
information technology to reduce diagnostic error. They will identify clinical and demographic variables of
patients with abnormal LFTs associated with specific liver-related diagnoses in primary care (Aim 1).
Additionally, they will develop and validate a predictive model to identify patients with abnormal LFTs at risk for
liver-related diagnoses (Aim 2). Lastly, they will create a decision support tool application to aid PCPs
confronted with abnormal LFTs to promptly and accurately diagnose liver disease (Aim 3).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving the Diagnosis and Fibrosis Risk Assessment of Nonalcoholic Fatty Liver Disease in Primary Care Patients with Abnormal Liver Chemistries
-
批准号:10452095
-
项目类别:
-
资助金额:$11.32万
-
财政年份:2022
-
负责人:Andrew David Schreiner
-
依托单位:
Improving the Diagnosis and Fibrosis Risk Assessment of Nonalcoholic Fatty Liver Disease in Primary Care Patients with Abnormal Liver Chemistries
-
批准号:10616810
-
项目类别:
-
资助金额:$11.33万
-
财政年份:2022
-
负责人:Andrew David Schreiner
-
依托单位:
Improving the Diagnosis of Liver Disease in Primary Care Patients with Abnormal Liver Function
-
批准号:10359758
-
项目类别:
-
资助金额:$17.25万
-
财政年份:2018
-
负责人:Andrew David Schreiner
-
依托单位:
海外基金